Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Amyloid-β1-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse.

Varga E, Juhász G, Bozsó Z, Penke B, Fülöp L, Szegedi V.

J Alzheimers Dis. 2015 Jan 1;45(2):449-56. doi: 10.3233/JAD-142367.

PMID:
25547631
2.

Mitochondrial Ca2+ uptake correlates with the severity of the symptoms in autosomal dominant optic atrophy.

Fülöp L, Rajki A, Maka E, Molnár MJ, Spät A.

Cell Calcium. 2015 Jan;57(1):49-55. doi: 10.1016/j.ceca.2014.11.008. Epub 2014 Dec 9.

PMID:
25533789
3.

Zygosaccharomyces favi sp. nov., an obligate osmophilic yeast species from bee bread and honey.

Čadež N, Fülöp L, Dlauchy D, Péter G.

Antonie Van Leeuwenhoek. 2015 Mar;107(3):645-54. doi: 10.1007/s10482-014-0359-1. Epub 2014 Dec 21.

PMID:
25528339
4.

Wall motion changes in myocardial infarction in relation to the time elapsed from symptoms until revascularization.

Rácz I, Fülöp L, Kolozsvári R, Szabó GT, Bódi A, Péter A, Kertész A, Hegedüs I, Edes I, Balkay L, Köszegi Z.

Anadolu Kardiyol Derg. 2014 Jul 11. doi: 10.5152/akd.2014.5457. [Epub ahead of print]

5.

Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors.

Varga E, Juhász G, Bozsó Z, Penke B, Fülöp L, Szegedi V.

Neural Plast. 2014;2014:584314. doi: 10.1155/2014/584314. Epub 2014 Sep 3.

6.

IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.

Liu Y, Liu X, Hao W, Decker Y, Schomburg R, Fülöp L, Pasparakis M, Menger MD, Fassbender K.

J Neurosci. 2014 Sep 24;34(39):12982-99. doi: 10.1523/JNEUROSCI.1348-14.2014.

7.

Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brain.

Borbély E, Horváth J, Furdan S, Bozsó Z, Penke B, Fülöp L.

Biomed Res Int. 2014;2014:345305. doi: 10.1155/2014/345305. Epub 2014 Jun 23.

8.

How best practices are copied, transferred, or translated between health care facilities: A conceptual framework.

Guzman G, Fitzgerald JA, Fulop L, Hayes K, Poropat A, Avery M, Campbell S, Fisher R, Gapp R, Herington C, McPhail R, Vecchio N.

Health Care Manage Rev. 2014 Apr 29. [Epub ahead of print]

PMID:
24787750
9.

Exploiting aromatic interactions for β-peptide foldamer helix stabilization: a significant design element.

Mándity IM, Monsignori A, Fülöp L, Forró E, Fülöp F.

Chemistry. 2014 Apr 14;20(16):4591-7. doi: 10.1002/chem.201304448. Epub 2014 Mar 24.

PMID:
24664416
10.

Extramitochondrial OPA1 and adrenocortical function.

Fülöp L, Rajki A, Katona D, Szanda G, Spät A.

Mol Cell Endocrinol. 2013 Dec 5;381(1-2):70-9. doi: 10.1016/j.mce.2013.07.021. Epub 2013 Jul 29.

PMID:
23906536
11.

Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit.

Veszelka S, Tóth AE, Walter FR, Datki Z, Mózes E, Fülöp L, Bozsó Z, Hellinger E, Vastag M, Orsolits B, Környei Z, Penke B, Deli MA.

J Alzheimers Dis. 2013;36(3):487-501. doi: 10.3233/JAD-120163.

PMID:
23645098
12.

Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.

Zilberter M, Ivanov A, Ziyatdinova S, Mukhtarov M, Malkov A, Alpár A, Tortoriello G, Botting CH, Fülöp L, Osypov AA, Pitkänen A, Tanila H, Harkany T, Zilberter Y.

J Neurochem. 2013 Apr;125(1):157-71. doi: 10.1111/jnc.12127. Epub 2013 Jan 10.

PMID:
23241062
13.

Leadership, clinician managers and a thing called "hybridity".

Fulop L.

J Health Organ Manag. 2012;26(4-5):578-604.

PMID:
23115906
14.

Conformational dynamics of titin PEVK explored with FRET spectroscopy.

Huber T, Grama L, Hetényi C, Schay G, Fülöp L, Penke B, Kellermayer MS.

Biophys J. 2012 Oct 3;103(7):1480-9. doi: 10.1016/j.bpj.2012.08.042. Epub 2012 Oct 2.

15.

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.

Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A.

Int Immunol. 2013 Jan;25(1):25-33. doi: 10.1093/intimm/dxs090. Epub 2012 Sep 7.

16.

A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.

Fülöp L, Mándity IM, Juhász G, Szegedi V, Hetényi A, Wéber E, Bozsó Z, Simon D, Benkő M, Király Z, Martinek TA.

PLoS One. 2012;7(7):e39485. doi: 10.1371/journal.pone.0039485. Epub 2012 Jul 30.

17.

The role of mitochondrial Ca(2+) and NAD(P)H in the control of aldosterone secretion.

Spät A, Fülöp L, Szanda G.

Cell Calcium. 2012 Jul;52(1):64-72. doi: 10.1016/j.ceca.2012.01.009. Epub 2012 Feb 23. Review.

PMID:
22364774
18.

The formation of amyloid-like fibrils of α-chymotrypsin in different aqueous organic solvents.

Simon LM, Laczkó I, Demcsák A, Tóth D, Kotormán M, Fülöp L.

Protein Pept Lett. 2012 May;19(5):544-50.

PMID:
22185498
19.

Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.

Lakatos A, Gyurcsik B, Nagy NV, Csendes Z, Wéber E, Fülöp L, Kiss T.

Dalton Trans. 2012 Feb 14;41(6):1713-26. doi: 10.1039/c1dt10989h. Epub 2011 Dec 13.

PMID:
22159144
20.

The effect of OPA1 on mitochondrial Ca²⁺ signaling.

Fülöp L, Szanda G, Enyedi B, Várnai P, Spät A.

PLoS One. 2011;6(9):e25199. doi: 10.1371/journal.pone.0025199. Epub 2011 Sep 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk